BusinessUCSF Enhances Cancer Assay with Interpretive Reporting Powered by GenomOncology’s GO Clinical WorkbenchBy Nasdaq OMXJun 27, 2017, 1:00 PM UTC
BusinessTempus and University of Chicago Medicine Collaborate on Pancreatic Cancer Research ProjectBy Nasdaq OMXJun 22, 2017, 2:30 PM UTC
BusinessThe American Academy of Anti-Aging Medicine (A4M) and Metabolic Medical Institute (MMI) announce agenda for their largest annual event, welcoming thousands of clinicians and exhibitors to the 25th World Congress in Las VegasBy Nasdaq OMXJun 9, 2017, 4:25 PM UTC
Business2X Oncology Obtains Investigational New Drug Application for 2X-111 Glutathione Enhanced PEGylated Liposomal DoxorubicinBy Nasdaq OMXJun 8, 2017, 1:06 PM UTC
BusinessGeneCentric Therapeutics Appoints Walter M. Capone as Chief Business Officer and Adds Ellen Lubman to Board of Directors as Company Advances Drug Development PlatformBy Nasdaq OMXMay 30, 2017, 11:03 AM UTC
BusinessGeneCentric Therapeutics Appoints Walter M. Capone as Chief Business Officer and Adds Ellen Lubman to Board of Directors as Company Advances Drug Development PlatformBy Nasdaq OMXMay 30, 2017, 11:03 AM UTC
BusinessGeneCentric Therapeutics Appoints Walter M. Capone as Chief Business Officer and Adds Ellen Lubman to Board of Directors as Company Advances Drug Development PlatformBy Nasdaq OMXMay 30, 2017, 11:03 AM UTC
